• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌临床试验的全球分析数据。

Data on global analysis of clinical trials with probiotics.

作者信息

Dronkers Theresia M G, Ouwehand Arthur C, Rijkers Ger T

机构信息

Department of Sciences, University College Roosevelt, Lange Noordstraat 1, 4331 CB Middelburg, the Netherlands.

DuPont Nutrition and Biosciences, Danisco Sweeteners Oy. Global Health and Nutrition Sciences, Sokeritehtaantie 20, Kantvik 02460, Finland.

出版信息

Data Brief. 2020 Sep 3;32:106269. doi: 10.1016/j.dib.2020.106269. eCollection 2020 Oct.

DOI:10.1016/j.dib.2020.106269
PMID:32964082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7490816/
Abstract

Data on characteristics of clinical trials with probiotics, registered at ClinicalTrials.gov were retrieved from the registry . Data on the registration process itself (moment of registration of the trial in relation to date of inclusion of first participant, data of completion of the study) as well as the number of participants were analysed. A trend analysis (over the period 2000-2020) was made of the number of participants in clinical trials with probiotics on gastrointestinal conditions and diseases. A comparison was made between conditions and diseases studied in completed clinical trials with those trials not yet recruiting participants. The data can be used and reused for assessment of the quality of clinical studies with probiotics and to identify future trends in applications of probiotics.

摘要

从ClinicalTrials.gov注册库中检索了有关益生菌临床试验特征的数据。分析了注册过程本身的数据(试验注册时间与第一名参与者纳入日期的关系、研究完成日期)以及参与者数量。对2000年至2020年期间胃肠道疾病益生菌临床试验的参与者数量进行了趋势分析。对已完成临床试验中研究的病症与尚未招募参与者的试验进行了比较。这些数据可用于评估益生菌临床研究的质量,并确定益生菌应用的未来趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/26cecc57dca3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/746049966eea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/4db890ebde3d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/9bb0a68c4442/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/dcde12a5f4a1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/c09a2c540c33/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/26cecc57dca3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/746049966eea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/4db890ebde3d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/9bb0a68c4442/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/dcde12a5f4a1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/c09a2c540c33/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1f/7490816/26cecc57dca3/gr6.jpg

相似文献

1
Data on global analysis of clinical trials with probiotics.益生菌临床试验的全球分析数据。
Data Brief. 2020 Sep 3;32:106269. doi: 10.1016/j.dib.2020.106269. eCollection 2020 Oct.
2
Global analysis of clinical trials with probiotics.益生菌临床试验的全球分析。
Heliyon. 2020 Jul 17;6(7):e04467. doi: 10.1016/j.heliyon.2020.e04467. eCollection 2020 Jul.
3
The fate of prospective spine studies registered on www.ClinicalTrials.gov.在www.ClinicalTrials.gov上注册的前瞻性脊柱研究的命运。
Spine J. 2015 Mar 1;15(3):487-91. doi: 10.1016/j.spinee.2014.10.008. Epub 2014 Oct 12.
4
Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013.全球临床试验注册趋势:对2004年至2013年世界不同地区注册临床试验数量的分析。
BMJ Open. 2015 Sep 25;5(9):e008932. doi: 10.1136/bmjopen-2015-008932.
5
Discrepancies between ClinicalTrials.gov recruitment status and actual trial status: a cross-sectional analysis.ClinicalTrials.gov招募状态与实际试验状态之间的差异:一项横断面分析。
BMJ Open. 2017 Oct 11;7(10):e017719. doi: 10.1136/bmjopen-2017-017719.
6
Probiotics for the Management of Infectious Diseases: Reviewing the State of the Art.用于传染病管理的益生菌:综述最新进展
Front Microbiol. 2022 Apr 28;13:877142. doi: 10.3389/fmicb.2022.877142. eCollection 2022.
7
Association between trial registration and treatment effect estimates: a meta-epidemiological study.试验注册与治疗效果估计之间的关联:一项元流行病学研究。
BMC Med. 2016 Jul 4;14(1):100. doi: 10.1186/s12916-016-0639-x.
8
Cochrane Commentary: Probiotics For Prevention of Acute Upper Respiratory Infection.考克兰评论:益生菌预防急性上呼吸道感染
Explore (NY). 2015 Sep-Oct;11(5):418-20. doi: 10.1016/j.explore.2015.07.012. Epub 2015 Jul 6.
9
Probiotics for patients with hepatic encephalopathy.用于肝性脑病患者的益生菌。
Cochrane Database Syst Rev. 2011 Nov 9(11):CD008716. doi: 10.1002/14651858.CD008716.pub2.
10
Funding source and primary outcome changes in clinical trials registered on ClinicalTrials.gov are associated with the reporting of a statistically significant primary outcome: a cross-sectional study.在ClinicalTrials.gov上注册的临床试验中,资金来源和主要结局的变化与具有统计学显著性的主要结局报告相关:一项横断面研究。
F1000Res. 2015 Mar 26;4:80. doi: 10.12688/f1000research.6312.2. eCollection 2015.

引用本文的文献

1
Natural Ingredients to Improve Immunity.增强免疫力的天然成分。
Pharmaceuticals (Basel). 2023 Apr 1;16(4):528. doi: 10.3390/ph16040528.
2
Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review.益生菌作为通过肠-心轴减少心肌重塑和心力衰竭的潜在治疗方法:最新综述
Mol Cell Biochem. 2023 Nov;478(11):2539-2551. doi: 10.1007/s11010-023-04683-6. Epub 2023 Mar 9.
3
subsp. HN019 Effects on Gut Health: A Review.亚种 HN019 对肠道健康的影响:综述

本文引用的文献

1
Global analysis of clinical trials with probiotics.益生菌临床试验的全球分析。
Heliyon. 2020 Jul 17;6(7):e04467. doi: 10.1016/j.heliyon.2020.e04467. eCollection 2020 Jul.
2
Probiotics and health: understanding probiotic trials.益生菌与健康:解读益生菌试验
N Z Med J. 2019 Jul 12;132(1498):90-96.
3
The pros, cons, and many unknowns of probiotics.益生菌的利与弊及诸多未知因素。
Front Nutr. 2021 Dec 14;8:790561. doi: 10.3389/fnut.2021.790561. eCollection 2021.
Nat Med. 2019 May;25(5):716-729. doi: 10.1038/s41591-019-0439-x. Epub 2019 May 6.
4
Probiotics in human health and disease: from nutribiotics to pharmabiotics.益生菌在人类健康和疾病中的作用:从营养益生菌到药物益生菌。
J Microbiol. 2018 Nov;56(11):773-782. doi: 10.1007/s12275-018-8293-y. Epub 2018 Oct 24.
5
The ascent of the blessed: regulatory issues on health effects and health claims for probiotics in Europe and the rest of the world.益生菌在欧洲和世界其他地区的健康影响和健康声称的监管问题:祝福的升华。
Benef Microbes. 2018 Sep 18;9(5):717-723. doi: 10.3920/BM2017.0196. Epub 2018 May 25.
6
The effects of probiotics on mood and emotion.益生菌对情绪和情感的影响。
JAAPA. 2018 May;31(5):1-3. doi: 10.1097/01.JAA.0000532122.07789.f0.
7
Health effects of probiotics on the skin.益生菌对皮肤的健康影响。
Crit Rev Food Sci Nutr. 2015;55(9):1219-40. doi: 10.1080/10408398.2012.680078.